Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT ‐based colorectal cancer screening
International Journal of Cancer · 01.05.2025 · 156 (9) · 1783-1790
DOI: 10.1002/ijc.35294 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 19.12.2024. Verfasst von Brenda J van Stigt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rijksinstituut voor Volksgezondheid en Milieu.
Abstract (Originalsprache)
Upper age limits are currently fixed for all fecal immunochemical test (FIT)‐based colorectal cancer (CRC) screening programs. A risk‐stratified upper age limit may be beneficial. Therefore, we assessed differences in interval CRC risk among individuals who had reached the upper age limit of screening (75 years). Individuals with a negative FIT (0 μg Hb/g feces. Among 305,761 individuals with a complete follow‐up (24 months), 661 were diagnosed with interval CRC (21.6 per 10,000 negative FITs). Individuals with detectable f‐Hb (15%) were 5 times more likely to be diagnosed with interval CRC than those without (HR 4.87, 95%CI: 4.19–5.65). Moreover, their cancers were more often detected at a late stage compared to individuals without detectable f‐Hb (OR 1.45, 95%CI: 1.06–2.01). Our results show that interval CRC risk among individuals aged ≥75 differs substantially by last f‐Hb concentration, indicating a uniform age to stop screening is suboptimal. Future research, taking into account multiple screening rounds and FIT results, should determine the optimal risk‐stratified screening strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Pathology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
- Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Gastrointestinal Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
ORCID-Profile: Brenda J van Stigt, Iris Lansdorp-Vogelaar, Esther Toes-Zoutendijk
Förderung
- Rijksinstituut voor Volksgezondheid en Milieu
Zitieren
APA
van Stigt, B. J., Lansdorp-Vogelaar, I., Spaander, M. C. W., van Vuuren, A. J., Dekker, E., van Kemenade, F. J., Nagtegaal, I. D., van Leerdam, M. E., & Toes-Zoutendijk, E. (2025). Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT ‐based colorectal cancer screening. International Journal of Cancer, 156(9), 1783-1790. https://doi.org/10.1002/ijc.35294
Vancouver
van Stigt BJ, Lansdorp-Vogelaar I, Spaander MCW, van Vuuren AJ, Dekker E, van Kemenade FJ, et al. Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT ‐based colorectal cancer screening. International Journal of Cancer. 2025;156(9):1783-1790. doi:10.1002/ijc.35294
BibTeX
@article{vanStigt2025,
author = {van Stigt, Brenda J and Lansdorp-Vogelaar, Iris and Spaander, Manon C W and van Vuuren, Anneke J and Dekker, Evelien and van Kemenade, Folkert J and Nagtegaal, Iris D and van Leerdam, Monique E and Toes-Zoutendijk, Esther},
title = {Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT ‐based colorectal cancer screening},
journal = {International Journal of Cancer},
year = {2025},
volume = {156},
number = {9},
pages = {1783--1790},
doi = {10.1002/ijc.35294}
}
EUVIMED